Stable isotope infusions (DrugBank: -)
1 diseaseID | Disease name (Link within this page) | Number of trials |
---|---|---|
96 | Crohn disease | 1 |
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT00583232 (ClinicalTrials.gov) | February 2006 | 20/12/2007 | Protein and Energy Metabolism in Pediatric Crohn's Disease | Protein and Energy Metabolism in Pediatric Crohn's Disease | Crohn's Disease;Protein Metabolism;Energy Metabolism | Drug: Stable isotope infusions | Indiana University | GlaxoSmithKline;Crohn's and Colitis Foundation;National Center for Research Resources (NCRR) | Completed | 6 Years | 18 Years | All | 15 | Phase 1 | United States |